2nd Quarter - Report

PHLOW CORPORATION for PHLOW CORPORATION

Firm
Client
Income
—
Expenses
$370,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY27 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R.9260); FY27 Department of Defense Appropriations (H.R.9495)

LobbyistCovered position, as disclosed
JOHN FUNDERBURK —
VALERIE HARDIN JEWETT —

Contacted: Office of Management & Budget (OMB); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9495 (119th), H.R. 9260 (119th)

Health Issues HCR

Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).

LobbyistCovered position, as disclosed
JOHN FUNDERBURK —
VALERIE HARDIN JEWETT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Economic Council (NEC); Defense, Dept of (DOD); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Bills named: S. 2062 (119th), S. 1784 (119th), H.R. 4191 (119th), H.R. 3966 (119th)

Manufacturing MAN

Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).

LobbyistCovered position, as disclosed
JOHN FUNDERBURK —
VALERIE HARDIN JEWETT —

Contacted: Office of Management & Budget (OMB); SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS)

Bills named: S. 1784 (119th), S. 2062 (119th), H.R. 4191 (119th), H.R. 3966 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.